Cargando…

Editorial: Quality Assessment Across Disciplines in Head and Neck Cancer Treatment

Detalles Bibliográficos
Autores principales:	Vermorken, Jan B., Van Gestel, Dirk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934614/ https://www.ncbi.nlm.nih.gov/pubmed/33680974 http://dx.doi.org/10.3389/fonc.2021.636622

Ejemplares similares

Quality Assessment Across Disciplines in Head and Neck Cancer Treatment Diagnostic Pathology in HNSCC
por: Sloan, Philip, et al.
Publicado: (2020)

Editorial: Head and neck cancer in the elderly
por: Szturz, Petr, et al.
Publicado: (2023)

Editorial: Insights in head and neck cancer: 2021
por: Lybaert, Willem, et al.
Publicado: (2023)

Follow-Up of Head and Neck Cancer Survivors: Tipping the Balance of Intensity
por: Szturz, Petr, et al.
Publicado: (2020)

Low-Dose vs. High-Dose Cisplatin: Lessons Learned From 59 Chemoradiotherapy Trials in Head and Neck Cancer
por: Szturz, Petr, et al.
Publicado: (2019)

Treatment of Elderly Patients with Squamous Cell Carcinoma of the Head and Neck
por: Szturz, Petr, et al.
Publicado: (2016)

Radiotherapy Quality Assurance for Head and Neck Squamous Cell Carcinoma
por: Van Gestel, Dirk, et al.
Publicado: (2020)

Head and Neck Cancer in Belgium: Quality of Diagnostic Management and Variability Across Belgian Hospitals Between 2009 and 2014
por: Leroy, Roos, et al.
Publicado: (2019)

Fast Helical Tomotherapy in a head and neck cancer planning study: is time priceless?
por: Van Gestel, Dirk, et al.
Publicado: (2015)

Restoring p53 Function in Head and Neck Squamous Cell Carcinoma to Improve Treatments
por: de Bakker, Tycho, et al.
Publicado: (2022)

Cisplatin Eligibility Issues and Alternative Regimens in Locoregionally Advanced Head and Neck Cancer: Recommendations for Clinical Practice
por: Szturz, Petr, et al.
Publicado: (2019)

Quality Assessment in Supportive Care in Head and Neck Cancer
por: Bonomo, Pierluigi, et al.
Publicado: (2019)

Editorial: Immunology and Immunotherapy of Head and Neck Cancer
por: Gavrielatou, Niki, et al.
Publicado: (2021)

Editorial: Women in head and neck cancer 2021
por: Economopoulou, Panagiota, et al.
Publicado: (2022)

Assessment and Improvement of Quality of Life in Patients Undergoing Treatment for Head and Neck Cancer
por: Majid, Aamina, et al.
Publicado: (2017)

Measurement of Sarcopenia in Head and Neck Cancer Patients and Its Association With Frailty
por: de Bree, Remco, et al.
Publicado: (2022)

Cetuximab: its unique place in head and neck cancer treatment
por: Specenier, Pol, et al.
Publicado: (2013)

Editorial: Advances in Head and Neck Cancer Immunology and Immunotherapy
por: Abu Eid, Rasha
Publicado: (2019)

Editorial: Next generation staging in head and neck cancers
por: Iyer, N. Gopalakrishna, et al.
Publicado: (2022)

Editorial: Prognosis prediction and risk stratification in head and neck cancer
por: Li, Tengxiang, et al.
Publicado: (2022)

Editorial: Challenges and their implications for the clinical practice of head and neck cancer
por: Wirth, Markus, et al.
Publicado: (2023)

Editorial: Women in head and neck cancer, volume II: 2022
por: Economopoulou, Panagiota, et al.
Publicado: (2023)

Editorial: Head & Neck Cancer and Esophageal Cancer: From Biosignatures to Therapeutics
por: Kok, Victor C., et al.
Publicado: (2021)

Immunotherapy in head and neck cancer: aiming at EXTREME precision
por: Szturz, Petr, et al.
Publicado: (2017)

Biologic Therapy in Head and Neck Cancer: A Road with Hurdles
por: Specenier, Pol, et al.
Publicado: (2012)

Translating KEYNOTE-048 into practice recommendations for head and neck cancer
por: Szturz, Petr, et al.
Publicado: (2020)

Editorial: Cycling: performance enhancement across the disciplines
por: Carmo, Everton Crivoi
Publicado: (2023)

Novel Diagnostic Approaches for Assessment of the Clinically Negative Neck in Head and Neck Cancer Patients
por: Driessen, Daphne A. J. J., et al.
Publicado: (2021)

Editorial: Advances in the Systemic Therapy and Combined Modality Approaches for Head and Neck Cancer
por: Argiris, Athanassios, et al.
Publicado: (2019)

The Role of Akt in Acquired Cetuximab Resistant Head and Neck Squamous Cell Carcinoma: An In Vitro Study on a Novel Combination Strategy
por: Zaryouh, Hannah, et al.
Publicado: (2021)

Head and Neck Cancer
por: Psyrri, Amanda, et al.
Publicado: (2009)

The Impact of Clinical Trial Quality Assurance on Outcome in Head and Neck Radiotherapy Treatment
por: Zhong, Haoyu, et al.
Publicado: (2019)

Editorial: “Non-Coding RNAs in Head and Neck Squamous Cell Carcinoma”
por: Cao, Wei, et al.
Publicado: (2021)

Assessment of cough in head and neck cancer patients at risk for dysphagia—An overview
por: Mootassim‐Billah, Sofiana, et al.
Publicado: (2021)

Quality Assessment in FDG-PET/CT Imaging of Head-and-Neck Cancer: One Home Run Is Better Than Two Doubles
por: Van den Wyngaert, Tim, et al.
Publicado: (2020)

Quality of Life of Patients After Treatment for Cancer in the Head and Neck Region: A Case-Control Study
por: Caetano, Rafael S, et al.
Publicado: (2022)

Head and neck cancers: Monitoring quality and reporting outcomes
por: Chilkuri, Madhavi, et al.
Publicado: (2021)

Treatment Stratification in First-Line Recurrent or Metastatic Head and Neck Cancer, on Behalf of the EORTC Young Investigator Head and Neck Cancer Group
por: Klinghammer, Konrad, et al.
Publicado: (2022)

Palliative Care and End-of-Life Issues in Elderly Cancer Patients With Head and Neck Cancer
por: Schrijvers, Dirk, et al.
Publicado: (2022)

Quality of Care Indicators for Head and Neck Cancers: The Experience of the European Project RARECAREnet
por: Trama, Annalisa, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7qpo0p5jg3g2pg9svf8lsta8sj